Oncodesign Precision Medicine (XPAR:ALOPM) Days Sales Outstanding : 1,064.30 (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Days Sales Outstanding?

Oncodesign Precision Medicine's average Accounts Receivable for the six months ended in Dec. 2024 was €0.62 Mil. Oncodesign Precision Medicine's Revenue for the six months ended in Dec. 2024 was €0.11 Mil. Hence, Oncodesign Precision Medicine's Days Sales Outstanding for the six months ended in Dec. 2024 was 1,064.30.

The historical rank and industry rank for Oncodesign Precision Medicine's Days Sales Outstanding or its related term are showing as below:

XPAR:ALOPM' s Days Sales Outstanding Range Over the Past 10 Years
Min: 19.12 Med: 71.1 Max: 1487.33
Current: 1487.33

During the past 5 years, Oncodesign Precision Medicine's highest Days Sales Outstanding was 1487.33. The lowest was 19.12. And the median was 71.10.

XPAR:ALOPM's Days Sales Outstanding is ranked worse than
97.29% of 849 companies
in the Biotechnology industry
Industry Median: 70.29 vs XPAR:ALOPM: 1487.33

Oncodesign Precision Medicine's Days Sales Outstanding increased from Dec. 2023 (539.97) to Dec. 2024 (1,064.30).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Oncodesign Precision Medicine Days Sales Outstanding Historical Data

The historical data trend for Oncodesign Precision Medicine's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Days Sales Outstanding Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

71.10

57.83

19.12

262.85

1,487.33

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Days Sales Outstanding	Get a 7-Day Free Trial			11.13	165.72	539.97	1,939.98	1,064.30

Competitive Comparison of Oncodesign Precision Medicine's Days Sales Outstanding

For the Biotechnology subindustry, Oncodesign Precision Medicine's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncodesign Precision Medicine's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncodesign Precision Medicine's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Oncodesign Precision Medicine's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Oncodesign Precision Medicine Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Oncodesign Precision Medicine's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (1.063	+	0.624)	/	2 )	/	0.207	*	365
=	0.8435					/	0.207	*	365
=	1,487.33

Oncodesign Precision Medicine's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding (Q: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2024 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (0	+	0.624)	/	1 )	/	0.107	*	365 / 2
=	0.624					/	0.107	*	365 / 2
=	1,064.30

Oncodesign Precision Medicine (XPAR:ALOPM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Oncodesign Precision Medicine Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

ZR8:Germany

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines